Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Hyperprolactinemia as a manifestation of multiple sclerosis attack
Sahand Golparvar1, Saba Naghavi1,2, Iman Adibi1,2
1Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
None:
Background: Multiple Sclerosis is a chronic inflamatory disorder. The prevalence of hyperprolactinemia in patient with MS is 6.7 %. Method: Case report. Result: This case report describes a 31-year-old woman with multiple sclerosis (MS) who presented with galactorrhea, a rare symptom of MS, along with other neurological manifestations. She had elevated serum prolactin levels and a normal-sized pituitary gland with no evidence of adenoma or lesions. The elevated serum prolactin levels were normalized after treatment with intravenous methylprednisolone. No dopaminergic drugs were used to treat her galactorrhea, which also resolved after receiving intravenous methylprednisolone. Conclusion: This case illustrates the possible association between MS and hyperprolactinaemia and if the etiology is MS there is no need for treatment of hyperprolactinemia.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Mania and Antimanic Drugs: Overview
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

